Table 1.1Stages in the NICE guideline development process and the versions followed at each stage

Stage2005 version142006 version152007 version16
Scoping the guideline (determining what the guideline would and would not cover)
Preparing the work plan (agreeing timelines, milestones, GDG constitution, etc.)
Forming and running the GDG
Developing clinical questions
Identifying the evidence
Reviewing and grading the evidence
Incorporating health economics
Making group decisions and reaching consensus
Linking guidance to other NICE guidance
Creating guideline recommendations
Developing clinical audit criteria
Writing the guideline
Validation (stakeholder consultation on the draft guideline)
Declaration of interestsa
a

The process for declaring interests was extended in November 2006 to cover NCC-WCH staff and to include personal family interests.

From: 1, Introduction

Cover of Atopic Eczema in Children
Atopic Eczema in Children: Management of Atopic Eczema in Children from Birth up to the Age of 12 Years.
NICE Clinical Guidelines, No. 57.
National Collaborating Centre for Women's and Children's Health (UK).
London: RCOG Press; 2007 Dec.
Copyright © 2007, National Collaborating Centre for Women’s and Children’s Health.

No part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK [www.cla.co.uk]. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.